GO
Loading...

Takeover Bids

More

  • Cramer eyes food fight     Tuesday, 27 May 2014 | 8:53 AM ET

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today Cramer shares his thoughts on Pilgrim Pride's bid for Hillshire Brands.

  • Plotting Pfizer's next move     Tuesday, 27 May 2014 | 6:20 AM ET

    John Eade, Argus Research, discusses Pfizer's likely next move after abandoning its attempt to buy AstraZeneca. There's a good chance AstraZeneca management could ask Pfizer to come back to the table, says Eade.

  • LONDON, May 26- AstraZeneca welcomed Pfizer's decision to abandon an attempt to buy the British drugmaker, which AstraZeneca said would allow it to focus on its growth as a standalone business. "We note Pfizer's confirmation that it no longer intends to make an offer for AstraZeneca.

  • LONDON/ NEW YORK, May 26- Pfizer said on Monday it had abandoned its current attempt to buy AstraZeneca for nearly 70 billion pounds as a deadline approached without a last-minute change of heart by the British drugmaker. Its decision to quit the stage, at least for now, had been widely expected after AstraZeneca refused its final offer of 55 pounds a share.

  • LONDON, May 25- The world's largest hotelier, Intercontinental Hotels Group, has rejected a 6 billion pound takeover offer from a U.S. bidder, Sky News reported, citing unidentified sources. A spokeswoman for IHG, which runs 4,700 hotels with brands such as Crowne Plaza, Holiday Inn and Intercontinental, declined to comment on the report.

  • May 23- Gentiva Health Services Inc said it adopted a poison pill, more than a week after the home healthcare services provider rejected a $533- million hostile bid from hospital operator Kindred Healthcare Inc.. Gentiva rejected Kindred's $14- per-share offer on May 15, saying it undervalued the company.

  • PARIS, May 23- The French market regulator has extended a deadline for shareholders of Club Mediterranee to decide on a 557 million euro takeover bid while it seeks clarity on the intentions of a new investor in the holidays group.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity Worldwide Investment, ranking 18th, backed the British company's stance.

  • LONDON, May 20- Bankers advising pharmaceuticals companies Pfizer and Britain's AstraZeneca are likely to miss out on $260- 340 million in fees after the U.S. company's final takeover bid was rejected on Monday.

  • *Strategic Holdings raises Club Med stake above 10 pct. *Source says Strategic Holdings opposed Gaillon Invest bid. *Strategic Holdings says does not want control of group.

  • SYDNEY, May 20- Australia's Treasury Wine Estates is betting its Penfolds brand and a cost-cutting new CEO will boost earnings and justify its decision to reject a $2.90 billion takeover offer from private equity giant Kohlberg Kravis Roberts& Co LP.

  • LAVAL, QUEBEC, May 20- Canada's Valeant Pharmaceuticals International said on Tuesday it will not make an all-cash bid for drugmaker Allergan Inc as many had expected last week when the company said it would improve its cash and stock offer for the Botox maker.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity, ranking 18th, backed the British company's stance.

  • May 20- Canada's Valeant Pharmaceuticals International Inc said it will not make an all-cash bid for drugmaker Allergan Inc as many had expected last week when the company said it would improve its cash and stock offer for the Botox maker.

  • Drug flops from 2004 haunt AstraZeneca investors Tuesday, 20 May 2014 | 9:37 AM ET

    *AstraZeneca has had more than fair share of flops in past. LONDON, May 20- AstraZeneca's confidence in its promising new drugs may have seen off Pfizer's $118 billion takeover bid for now, but investors are left contemplating the lessons from 2004, when it was also trumpeting its product pipeline.

  • LONDON, May 20- AstraZeneca shareholder Schroders urged the company to restart takeover talks with Pfizer, adding its voice to criticism of the British drugmaker's rejection of the U.S. firm's 70 billion pound bid. Schroders is AstraZeneca's twelfth-largest shareholder with a 2 percent stake.

  • *Strategic Holdings raises Club Med stake above 10 pct. Source says Strategic Holdings opposed Gaillon Invest bid. Club Med declined to comment, while Gaillon Invest said it was waiting for Strategic Holdings to clarify its intentions.

  • SYDNEY, May 20- Australia's Treasury Wine Estates, the world's second biggest winemaker by sales, said it rejected a A $3.1 billion takeover offer from private equity giant Kohlberg Kravis Roberts& Co LP on the grounds that it was too low.

  • Pfizer's final bid rejected     Monday, 19 May 2014 | 2:17 PM ET

    $117 billion was not enough for AstraZeneca. CNBC's Meg Tirrell looks at Pfizer and AstraZeneca's stocks.

  • Next big takeover     Monday, 19 May 2014 | 2:12 PM ET

    CNBC's Herb Greenberg plays a game of "deal or no deal" and rounds up potential next takeover targets.